CYP3A5 Polymorphisms and Conversion to Once-Daily, Extended-Release Tacrolimus in Lung Transplant (LTx)

被引:0
|
作者
Ahmed, S. K. [1 ]
Seethamraju, H. [1 ]
机构
[1] Montefiore Med Ctr, Adv Pulm Failure & Lung Transplantat, 111 E 210th St, Bronx, NY 10467 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
790
引用
收藏
页码:S320 / S320
页数:1
相关论文
共 50 条
  • [21] Conversion to once-daily tacrolimus extended-release formulation (TAC XL) in renal transplantation: A multicenter experience in Argentina
    Maldonado, Rafael
    Soler Pujol, Gervasio
    Rodriguez, Marisol
    Sleiman, Jihan
    Carbel, Santiago
    Sabatiello, Roberto
    Petrone, Hugo
    Taylor, Fabian
    Imperiali, Nora
    Groppa, Roxana
    Grillo, Silvina
    Lopez, Fabian
    Gomez, Monica
    Diaz, Carlos
    Gaite, Luis
    Gaite, Judith
    Rafaelle, Pablo
    Mos, Fernando
    Schiavelli, Ruben
    [J]. TRANSPLANTATION, 2016, 100 (07) : S719 - S719
  • [22] Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant
    DuBay, Derek A.
    Teperman, Lewis
    Ueda, Kimi
    Silverman, Andrew
    Chapman, William
    Alsina, Angel E.
    Tyler, Carmelina
    Stevens, Daniel R.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (08): : 995 - 1008
  • [23] Influence on MDR1 and CYP3A5 Polymorphisms on the Pharmacokinetic of Once Daily Formulation of Tacrolimus in Liver Transplant Patients
    Bramuglia, G. F.
    Cairo, F.
    Buendia, J.
    De Davila, M.
    Schaiquevich, P.
    Otamendi, E.
    Powarzniak, Y.
    Nafissi, J.
    Ruf, A.
    Villamil, F.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1184 - 1184
  • [24] SINGLE NUCLEOTIDE POLYMORPHISMS OF CYP3A SUBFAMILY AND P-GLYCOPROTEIN INFLUENCE PHARMACOKINETICS OF ONCE-DAILY EXTENDED RELEASE TACROLIMUS IN LIVER TRANSPLANT RECIPIENTS
    Iacob, Speranta
    Maschmeier, Miriam
    Wu, Gang
    Kabar, Iyad
    Huesing, Anna
    Schmidt, Hartmut
    Cicinnati, Vito
    Beckebaum, Susanne
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 330 - 330
  • [25] Once-Daily Extended Release Tacrolimus Pharmacokinetics Is Influenced By Single Nucleotide Polymorphisms of CYP3A Subfamily and MDR-1 in Liver Transplant Recipients
    Iacob, Speranta
    Maschmeier, Miriam
    Wu, Gang
    Kabar, Iyad
    Huesing, Anna
    Schmidt, Hartmut H. J.
    Cicinnati, Vito
    Beckebaum, Susanne
    [J]. TRANSPLANTATION, 2015, 99 : 150 - 150
  • [26] Dosing and Outcomes of Conversion to Extended-Release Tacrolimus in Lung Transplant Recipients
    Doligalski, C. T.
    Walter, K. S.
    Evans, R. A.
    White, C. M.
    Krishnan, S.
    Coakley, R. D.
    Lobo, L. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S504 - S505
  • [27] ONCE-DAILY, EXTENDED-RELEASE GEMFIBROZIL IN PATIENTS WITH DYSLIPIDEMIA
    GOTTO, AM
    BREEN, WJ
    CORDER, CN
    DUNN, JK
    GOLDBERG, A
    KNOPP, RH
    SCHROTT, H
    SPRECHER, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (12): : 1057 - 1063
  • [28] Pharmacokinetic profile of once-daily cyclobenzaprine extended-release
    Darwish, Mona
    Hellriegel, Edward T.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1425 - 1436
  • [29] Cost Analysis of Once Daily Extended-Release Tacrolimus & Twice Daily Immediate-Release Tacrolimus for Kidney Transplant Recipients
    Hayes, C.
    Chelewski, R.
    Rodriguez, K.
    Zuckerman, A. D.
    Lynch, B.
    Moore, R.
    Choi, L.
    Bell, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S689 - S689
  • [30] Once-daily extended-release liquid for ADHD approved
    不详
    [J]. NURSE PRACTITIONER, 2018, 43 (01): : 56 - 56